Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

BACKGROUND Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective surveillance data to determine disease burden and secular trends are lacking. METHODS The Transplant-Associated Infection Surveillance Network (TRANSNET) is a consortium of 23 US transplant centers, including 15 that contributed to the organ transplant recipient dataset. We prospectively identified IFIs among organ transplant recipients from March, 2001 through March, 2006 at these sites. To explore trends, we calculated the 12-month cumulative incidence among 9 sequential cohorts. RESULTS During the surveillance period, 1208 IFIs were identified among 1063 organ transplant recipients. The most common IFIs were invasive candidiasis (53%), invasive aspergillosis (19%), cryptococcosis (8%), non-Aspergillus molds (8%), endemic fungi (5%), and zygomycosis (2%). Median time to onset of candidiasis, aspergillosis, and cryptococcosis was 103, 184, and 575 days, respectively. Among a cohort of 16,808 patients who underwent transplantation between March 2001 and September 2005 and were followed through March 2006, a total of 729 IFIs were reported among 633 persons. One-year cumulative incidences of the first IFI were 11.6%, 8.6%, 4.7%, 4.0%, 3.4%, and 1.3% for small bowel, lung, liver, heart, pancreas, and kidney transplant recipients, respectively. One-year incidence was highest for invasive candidiasis (1.95%) and aspergillosis (0.65%). Trend analysis showed a slight increase in cumulative incidence from 2002 to 2005. CONCLUSIONS We detected a slight increase in IFIs during the surveillance period. These data provide important insights into the timing and incidence of IFIs among organ transplant recipients, which can help to focus effective prevention and treatment strategies.

[1]  David Burgner,et al.  HLA and Infectious Diseases , 2009, Clinical Microbiology Reviews.

[2]  A. Bingaman,et al.  Campath Induction for Kidney Transplantation: Report of 297 Cases , 2008, Transplantation.

[3]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  H. Antretter,et al.  Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  J. Fechner,et al.  CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath‐1H , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  R. Betts,et al.  Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  N. Milman,et al.  Aspergillus infection in lung transplant patients: incidence and prognosis , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  D. Diso,et al.  Incidence of fungal infections in a solid organ recipients dedicated intensive care unit. , 2007, Transplantation proceedings.

[9]  R. Betts,et al.  Anidulafungin versus fluconazole for invasive candidiasis. , 2007, The New England journal of medicine.

[10]  S. Husain,et al.  Fungal infections in solid organ transplantation. , 2007, Medical mycology.

[11]  D. Pakstis,et al.  Voriconazole Prophylaxis in Lung Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  Rima A. Mohammad,et al.  Inhaled Amphotericin B for Prophylaxis Against Invasive Aspergillus Infections , 2006, The Annals of pharmacotherapy.

[13]  C. Agustí,et al.  Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. , 2005, Transplantation proceedings.

[14]  C. Viscoli,et al.  Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial , 2005, The Lancet.

[15]  R. Gilroy,et al.  Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center , 2005, Transplant infectious disease : an official journal of the Transplantation Society.

[16]  P. Muñoz,et al.  Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  R. Kandaswamy,et al.  Calcineurin Inhibitor- and Steroid-Free Immunosuppression in Pancreas-Kidney and Solitary Pancreas Transplantation , 2005, Transplantation.

[18]  A. Webster,et al.  Antifungal agents for preventing fungal infections in solid organ transplant recipients. , 2004, The Cochrane database of systematic reviews.

[19]  Lee H. Harrison,et al.  Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program , 2004, Journal of Clinical Microbiology.

[20]  Patty W. Wright,et al.  Donor-related coccidioidomycosis in organ transplant recipients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  N. J. Mueller,et al.  Asymptomatic pulmonary cryptococcosis in solid organ transplantation: report of four cases and review of the literature , 2003, Transplant infectious disease : an official journal of the Transplantation Society.

[22]  J. Fung,et al.  Longitudinal study of cryptococcosis in adult solid-organ transplant recipients , 2003, Transplant international : official journal of the European Society for Organ Transplantation.

[23]  Nina Singh,et al.  Fungal infections in the recipients of solid organ transplantation. , 2003, Infectious disease clinics of North America.

[24]  N. Smedira,et al.  The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[25]  P. Martín-Dávila,et al.  Risk factors for invasive aspergillosis in liver transplant recipients , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  J. Fung,et al.  Cryptococcosis in Organ Transplant Recipients: An Overview , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  R. Patel Infections in recipients of kidney transplants. , 2001, Infectious disease clinics of North America.

[28]  Nina Singh,et al.  Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. , 2001, Emerging infectious diseases.

[29]  N. Singh Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  P. Grossi,et al.  Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. , 2000, Transplantation.

[31]  Scott B. Johnson,et al.  Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients , 2000, Transplant infectious disease : an official journal of the Transplantation Society.

[32]  D. Dunn,et al.  Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. , 1996, Journal of the American College of Surgeons.

[33]  S. Todo,et al.  Infectious complications after small bowel transplantation in adults: an update. , 1996, Transplantation proceedings.

[34]  A. Karchmer,et al.  Fungal infections in solid organ transplant recipients. , 1995, Infectious disease clinics of North America.

[35]  M. Samore,et al.  Risk factors for invasive fungal infections complicating orthotopic liver transplantation. , 1994, The Journal of infectious diseases.